1-Phenyl-1,2-dihydroisoquinolin-3(4H)-one, 95.0%, 5g

METHYL 3-(5-FLUORO-2-METHOXYPHENYL)-3-OXOPROPANOATE, 95.0%, 10g

Tert-butyl (S)-(2-oxocyclohexyl)carbamate, 98%, 1g

trans-o-Coumaric Acid>98.0%(GC)(T)25g

D-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester, hydrochloride (1:1), 97%, 5g

1-Chloroimidazo[1,5-a]pyridine, 95+%, 100mg

6-BROMO-3-CHLORO-1-METHYL-1H-INDAZOLE, 95.0%, 10g

1-(6-(Trifluoromethyl)pyridin-2-yl)ethanone, 97.0%, 100mg

(R)-2-(Aminomethyl)-4-methylpentanoic acid hydrochloride, 95.0%, 100mg

1-Dodecylimidazolidine-2,4-dione, 97%, 5g

5-Bromo-2-phenylthiazole, 95.0%, 10g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 250mg

tert-Butyl 5-bromo-1H-indazole-1-carboxylate, 98.0%, 1g